Experts demand better prevention, treatment for children with hepatitis

November 3, 2017

A microscopic image of the Hepatitis B virus, taken by the Centers for Disease Control and Prevention
Experts at the second World Hepatitis Summit Friday called for improved preventative measures and treatment for 52 million children suffering from the disease, on the final day of the three-day event in Sao Paulo.

Of 325 million confirmed patients worldwide, 52 million are minors—a number far higher than the 2.1 million children suffering from AIDS, according to figures provided at the summit.

"Most infected infants and children are not diagnosed, prioritized or treated effectively," Raquel Peck, CEO of World Hepatitis Alliance (WHA), said in a statement.

Hepatitis is an inflammation of the liver caused by a virus. There are five types, but B and C are responsible for more than half of all new cases of , according to the World Health Organization.

Often transmitted from mothers, 48 million children have type B. But experts drew attention to increased diagnoses of C, for which no vaccine exists—and expressed concerns about the lack of .

Data released at the summit indicated 84 percent of countries offer hepatitis B vaccines—but only 39 percent provide the necessary dose at birth.

"Enough is enough. Governments and global health organizations must ensure all are vaccinated for hepatitis B and provided with DAAs (direct-acting antivirals) for hepatitis C, and that all pregnant women are screened," said Charles Gore, President of the World Hepatitis Alliance.

Last year, 194 countries pledged to take steps to eradicate hepatitis—a liver inflammation which kills 1.3 million people each year—by 2030. However, only nine are now honoring that commitment, according to figures released Wednesday.

Explore further: Worldwide 52 million children living with viral hepatitis

Related Stories

Worldwide 52 million children living with viral hepatitis

November 3, 2017
New data presented at this year's World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) show that 52 million children are living with viral hepatitis worldwide, compared to 2.1 million children living with HIV/AIDS.

Only nine countries on track to eliminate hepatitis C

November 1, 2017
New data on hepatitis C released by the Polaris Observatory, and presented today at the World Hepatitis Summit (WHS) in Sao Paulo, Brazil shows that nine countries—Australia, Brazil, Egypt, Georgia, Germany, Iceland, Japan, ...

Countries risk 'running out' of hepatitis C patients to treat, says World Hepatitis Alliance

November 1, 2017
The latest data on the global hepatitis C epidemic, released today at the World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) reveal that most countries (especially high-income countries) are running out of patients ...

UK elimination of hepatitis C in jeopardy unless more patients found

November 1, 2017
Just one in three people with hepatitis C in the UK have been diagnosed according to the latest estimates released at this year's World Hepatitis Summit in Sao Paulo, Brazil (1-3 November).

Cases of hepatitis B and C hit 325 million: WHO

April 21, 2017
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition, with death tolls from the viruses rising, the UN said Friday.

FDA approves hep C drugs for kids 12 and older

April 7, 2017
(HealthDay)—The U.S. Food and Drug Administration has approved two drugs to treat hepatitis C infection in children aged 12 and older.

Recommended for you

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

Faecal transplants, 'robotic guts' and the fight against deadly gut bugs

December 13, 2018
A simple compound found in our gut could help to stop dangerous bacteria behind severe, and sometimes fatal, hospital infections.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.